Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation.

Future Med Chem

Department of Therapeutic Chemistry, Pharmaceutical & Drug Industries Research Institute, National Research Centre, Dokki, Giza, 12622, Egypt.

Published: December 2023

Design and synthesis of a series of hydrazone-sulfonate hybrids, . The inhibitory properties of the synthesized compounds against acetylcholinesterase and butyrylcholinesterase were evaluated using donepezil as the reference standard. Compound was identified as the most potent inhibitor of acetylcholinesterase (IC = 9.30 μM), and compound was the most potent inhibitor of butyrylcholinesterase (IC = 11.82 μM). To confirm the safety of the most potent hits at the used doses, toxicological bioassays were conducted. Molecular docking was performed and the tested derivatives were found to fit well in the active sites of both enzymes. This study provides valuable insights into the potential of hydrazone-sulfonate hybrids as drug candidates.

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc-2023-0238DOI Listing

Publication Analysis

Top Keywords

hydrazone-sulfonate hybrids
12
design synthesis
8
potent inhibitor
8
hybrids potential
4
potential cholinesterase
4
cholinesterase inhibitors
4
inhibitors design
4
synthesis molecular
4
molecular modeling
4
modeling simulation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!